457 related articles for article (PubMed ID: 15740492)
1. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
[TBL] [Abstract][Full Text] [Related]
2. Association of porphyria cutanea tarda with hereditary hemochromatosis.
Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.
Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M
Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559
[TBL] [Abstract][Full Text] [Related]
5. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
[TBL] [Abstract][Full Text] [Related]
6. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
Wolff CF; Armas RM; Frank J; Poblete PG
Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
8. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
Bonkovsky HL; Poh-Fitzpatrick M; Pimstone N; Obando J; Di Bisceglie A; Tattrie C; Tortorelli K; LeClair P; Mercurio MG; Lambrecht RW
Hepatology; 1998 Jun; 27(6):1661-9. PubMed ID: 9620340
[TBL] [Abstract][Full Text] [Related]
9. Co-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium?
Cardoso CS; Alves H; Mascarenhas M; Gonçalves R; Oliveira P; Rodrigues P; Cruz E; de Sousa M; Porto G
Immunogenetics; 2002 Mar; 53(12):1002-8. PubMed ID: 11904676
[TBL] [Abstract][Full Text] [Related]
10. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
11. Linkage disequilibrium between S65C HFE mutation and HLA A29-B44 haplotype in Terceira Island, Azores.
Couto AR; Peixoto MJ; Garrett F; Laranjeira F; Cipriano T; Armas JB
Hum Immunol; 2003 Jun; 64(6):625-8. PubMed ID: 12770794
[TBL] [Abstract][Full Text] [Related]
12. HLA haplotypes associated with hemochromatosis mutations in the Spanish population.
Pacho A; Mancebo E; del Rey MJ; Castro MJ; Oliver D; García-Berciano M; González L; Morales P
BMC Med Genet; 2004 Oct; 5():25. PubMed ID: 15498100
[TBL] [Abstract][Full Text] [Related]
13. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands.
Barton JC; Sawada-Hirai R; Rothenberg BE; Acton RT
Blood Cells Mol Dis; 1999; 25(3-4):147-55. PubMed ID: 10575540
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
[TBL] [Abstract][Full Text] [Related]
15. Significance of H63D homozygosity in a Basque population with hemochromatosis.
Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
[TBL] [Abstract][Full Text] [Related]
16. C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria.
Ivanova A; von Ahsen N; Adjarov D; Krastev Z; Oellerich M; Wieland E
Hepatology; 1999 Dec; 30(6):1531-2. PubMed ID: 10610354
[No Abstract] [Full Text] [Related]
17. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP
Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077
[TBL] [Abstract][Full Text] [Related]
18. Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.
Hift RJ; Corrigall AV; Hancock V; Kannemeyer J; Kirsch RE; Meissner PN
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):853-9. PubMed ID: 12699243
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.
Roberts AG; Whatley SD; Morgan RR; Worwood M; Elder GH
Lancet; 1997 Feb; 349(9048):321-3. PubMed ID: 9024376
[TBL] [Abstract][Full Text] [Related]
20. Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.
Nagy Z; Kószó F; Pár A; Emri G; Horkay I; Horányi M; Karádi O; Rumi G; Morvay M; Varga V; Dobozy A; Mózsik G
Liver Int; 2004 Feb; 24(1):16-20. PubMed ID: 15101996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
